Teva Pharmaceutical (TEVA) news
Recent news
Medincell - Reports EUR 84.80 mln cash and cash equivalents as of March 31, 2026
MedinCell S.A. (EPA: MEDCL) reported holding EUR 84.80 million in cash and cash equivalents as of March 31, 2026. This figure reflects the company’s liquidity position at the end of the first quarter of 2026 and underscores its financial capacity to support ongoing research and development…
AInvest Wire · 1d agoMoody's Ratings affirms WePA's BA3 CFR, changes outlook to stable from positive
AInvest Wire · 1d agoTavexia Lifecare - Board approves acquisition of 60% controlling stake in Meyonex Pharmaceuticals
Tavexia Lifecare Limited (TAVX) has announced that its board of directors has approved the acquisition of a 60% controlling stake in Meyonex Pharmaceuticals. The move is expected to strengthen Tavexia’s position in the pharmaceutical sector by expanding its product portfolio and enhancing its…
AInvest Wire · 2d agoTeva: Oppenheimer raises target price to $52 from $50
AInvest Wire · 3d agoTelia - Reiterates 2026 financial outlook and mid-term financial targets
AInvest Wire · 3d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.